New Technology
Friday, 7/3, 04:38 PM
Anthropic says it will start developing its own drugs, with help from Claude
- The AI company Anthropic, maker of the Claude chatbot, says it is starting an in-house drug-discovery effort and launching a product, Claude Science, aimed at pharmaceutical researchers.
- The company frames the move as a way to test its own tools on real scientific problems — and says it will focus on 'neglected' diseases that big drugmakers often overlook.